Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics

Li, Na; Liu, Yun-He; Wu, Ji; Liu, Qiu-Ge; Niu, Jin-Bo; Zhang, Yan; Fu, Xiang-Jing; Song, Jian; Zhang, Sai-Yang

doi:10.1016/j.ejmech.2024.116694

European Journal of Medicinal Chemistry

2024

DOI: 10.1016/j.ejmech.2024.116694

|View full text |Cite

Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics

Na Li,

Yun-He Liu,

Ji Wu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 135 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

What are the essential determinants of human papillomavirus carcinogenesis?

Munger,

White

2024

mBio

View full text Add to dashboard Cite

Human papillomavirus (HPV) infection is the leading viral cause of cancer. Over the past several decades, research on HPVs has provided remarkable insight into human cell biology and into the pathology of viral and non-viral cancers. The HPV E6 and E7 proteins engage host cellular proteins to establish an environment in infected cells that is conducive to virus replication. They rewire host cell signaling pathways to promote proliferation, inhibit differentiation, and limit cell death. The activity of the “high-risk” HPV E6 and E7 proteins is so potent that their dysregulated expression is sufficient to drive the initiation and maintenance of HPV-associated cancers. Consequently, intensive research efforts have aimed to identify the host cell targets of E6 and E7, in part with the idea that some or all of the virus-host interactions would be essential cancer drivers. These efforts have identified a large number of potential binding partners of each oncoprotein. However, over the same time period, parallel research has revealed that a relatively small number of genetic mutations drive carcinogenesis in most non-viral cancers. We therefore propose that a high-priority goal is to identify which of the many targets of E6 and E7 are critical drivers of HPV carcinogenesis. By identifying the cancer-driving targets of E6 and E7, it should be possible to better understand the distinct roles of other targets, perhaps in the viral life cycle, and to focus efforts to develop anti-cancer therapies on the subset of virus-host interactions for which therapeutic intervention would have the greatest impact.

show abstract

What are the essential determinants of human papillomavirus carcinogenesis?

Munger,

White

2024

mBio

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics

Cited by 1 publication

References 135 publications

What are the essential determinants of human papillomavirus carcinogenesis?

What are the essential determinants of human papillomavirus carcinogenesis?

Contact Info

Product

Resources

About